Lee's Pharmaceutical Holdings Limited
LPCUF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $860,812 | $460 | $460 | $5,277,365 |
| - Cash | $216,845 | $171,000 | $189,301 | $277,529 |
| + Debt | $227,298 | $204,140 | $163,494 | $267,138 |
| Enterprise Value | $871,265 | $33,600 | -$25,347 | $5,266,974 |
| Revenue | $1,399,969 | $1,053,034 | $1,233,148 | $1,266,157 |
| % Growth | 32.9% | -14.6% | -2.6% | – |
| Gross Profit | $753,355 | $551,311 | $770,755 | $806,284 |
| % Margin | 53.8% | 52.4% | 62.5% | 63.7% |
| EBITDA | $259,667 | $191,563 | $229,059 | $2,125,450 |
| % Margin | 18.5% | 18.2% | 18.6% | 167.9% |
| Net Income | $93,099 | $16,698 | $51,284 | $1,987,176 |
| % Margin | 6.7% | 1.6% | 4.2% | 156.9% |
| EPS Diluted | 0.16 | 0.028 | 0.087 | 3.37 |
| % Growth | 463.4% | -67.4% | -97.4% | – |
| Operating Cash Flow | $242,012 | $110,082 | $283,634 | $210,683 |
| Capital Expenditures | -$207,559 | -$159,712 | -$213,825 | -$370,725 |
| Free Cash Flow | $34,453 | -$45,890 | $69,809 | -$160,042 |